Expertise in
12
conditions

Ryu Ishihara

Otemae, JP 
Expertise in
12
conditions
Otemae, JP 

Overview

Ryu Ishihara practices in Otemae, Japan. Mr. Ishihara is highly rated in 12 conditions, according to our data. His top areas of expertise are Esophageal Cancer, Stomach Cancer, Familial Adenomatous Polyposis, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 314 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Otemae, 5418567, Japan
Other Locations
Osaka, Japan
Chuo, 5418567, Japan
Tokyo, Japan
Chuo, 5418567, Japan
Itami, Japan
Sanda, Japan
Nakamichi, 5378511, Japan
Suita, 5650871, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: July 29, 2025
Intervention Type: Drug, Biological
Study Drugs: Cisplatin, Capecitabine, Paclitaxel, Fluorouracil (5-FU), Oxaliplatin, Tislelizumab
Study Phase: Phase 3

314 Total Publications

Gastric-Type Mixed Neoplastic and Non-Neoplastic Lesions in the Duodenal Bulb: A Case Supporting the Metaplasia-Neoplasia Sequence.
Gastric-Type Mixed Neoplastic and Non-Neoplastic Lesions in the Duodenal Bulb: A Case Supporting the Metaplasia-Neoplasia Sequence.
Journal: Diagnostics (Basel, Switzerland)
Published: February 18, 2026

Frequently Asked Questions about Ryu Ishihara

Is Ryu Ishihara a top-rated expert for Esophageal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Ryu Ishihara is classified as an Elite expert for Esophageal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ryu Ishihara participate in research or clinical trials?

Yes. Ryu Ishihara has published 314 articles and abstracts on conditions like Esophageal Cancer. You can view a list of Ryu Ishihara's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ishihara's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile